NIH Associate Director for Research on Women’s Health and ORWH Director, Janine Austin Clayton, M.D., FARVO, has authored a new publication, "Raising the Bar: Putting Science to Work for the Health of Women."
Learn More
A new article by ORWH Health Science Policy Analyst Raven Hardy Richard, Ph.D., titled “A Conceptual Model to Achieve Health Equity in APOL-1 Clinical Studies,” identifes challenges and opportunities related to enhancing clinical study participation diversity for individuals with kidney disease.
Learn More
Medscape and the Women’s Brain Foundation collaborated with ORWH Director, Janine Austin Clayton, M.D., FARVO, on a new continuing medical education program, “The Female Void: Sex and Gender Considerations in Health Care with a Focus on the Female Brain.”
Learn More
ORWH Participates in ODP Funding Opportunity to Support Expansion of Cancer Screenings in Populations that Experience Health Disparities
In collaboration with ORWH and other participating NIH institutes, centers, and offices, the Office of Disease Prevention is seeking applications for “Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities.”
Learn More
Read In the Spotlight Articles
 Advancing Health Equity through Interventions to Prevent and Address Housing Instability (R01 Clinical Trial Optional) (RFA-NR-25-001)
Expiration date: December 14, 2024
NOSI: Support for Conferences and Scientific Meetings to Support Consensus Building for Autoimmune Disease Research Related Common Data Elements (NOT-OD-24-145)
Submission dates follow the NIH standard due dates
Expiration date: December 14, 2026
Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs)
(RFA-DE-25-001), (RFA-DE-25-002)
Application due dates: November 20, 2024
Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional) (PAR-22-097), (PAR-22-098)
Application due dates: November 15, 2024
Notice of ORWH's Participation in PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications
(PA-24-247), (PA-24-248)
Due dates: January 5, 2025
Notice of ORWH participation in NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) (PAR-23-183)
Application due date: February 26, 2025
NOSI: Autoimmune Inner Ear Disease (Clinical Trials Not Allowed) (NOT-DC-25-003)
Expiration date: October 17, 2027
Additional Funding Opportunities
|
